SHINKEI THERAPEUTICS GETS FDA CLEARANCE FOR MR-101 TRIAL & COMPLETES PHASE 2 FOR MR-301 IN ...

SHINKEI THERAPEUTICS RECEIVES FDA CLEARANCE TO PROCEED WITH PHASE 1 CLINICAL TRIAL FOR MR-101 AND COMPLETES PHASE 2 ...